JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 31 No. 8 1364-1369
© 1990 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenberg, J. H.
Right arrow Articles by Reivich, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenberg, J. H.
Right arrow Articles by Reivich, M.

Validation Studies of Iodine-123-Iodoamphetamine as a Cerebral Blood Flow Tracer Using Emission Tomography

Joel H. Greenberg, Michael Kushner, Mario Rango, Abass Alavi and Martin Reivich

Cerebrovascular Research Center, Departments of Neurology and Radiology, University of Pennsylvania, Philadelphia, Pennsylvania

Correspondence: For reprints contact: Joel H. Greenberg, PhD, Cerebrovascular Research Center, 429 Johnson Pavilion, University of Pennsylvania, Philadelphia, PA 19104.

ABSTRACT

We studied the radioisotope iodine-123-iodoamphetamine ([123I]IMP) and its performance in single-photon emission computed tomographic (SPECT) studies of cerebral blood flow (CBF). In seven normal volunteers, IMP/SPECT CBF measurements were calculated using a two-compartment model and were compared with the results of CBF measurements utilizing (O15)-H2O and positron emission tomography (PET). Calculated mean PET CBF was 57.6 ml/100g/min while the SPECT CBF value was 47.3 ml/100 g/min. The response of IMP/SPECT CBF to alterations in arterial PaCO2 was studied in hypo-, eu- and hypercarbic subjects. SPECT CBF values showed a reactivity of 1.03 ml/100 g/min per mmHg PaC02 change.These results show that the IMP/SPECT CBF technique may be used for quantitative imaging of CBF in man. They provide further support for IMP as a CBF tracer.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
A. S. Arbab, S. Aoki, K. Toyama, N. Miyazawa, H. Kumagai, T. Umeda, T. Arai, T. Araki, H. Kabasawa, and Y. Takahashi
Quantitative Measurement of Regional Cerebral Blood Flow with Flow-Sensitive Alternating Inversion Recovery Imaging: Comparison with [Iodine 123]-Iodoamphetamin Single Photon Emission CT
AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 381 - 388.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1990 by the Society of Nuclear Medicine.